Better Therapeutics Inc. (BTTX)
undefined
undefined%
At close: undefined
0.01
7300.00%
Pre-market Jun 20, 2024, 09:30 AM EDT

Cashflow (Annual)

Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
Year FY22 FY21 FY20 FY19
Net Income -39.76M -40.34M -6.39M -5.78M
Depreciation & Amortization 2.73M 1.62M 75.00K 72.00K
Stock-Based Compensation 1.82M 646.00K 233.00K 84.00K
Other Working Capital 4.76M -3.35M 125.00K -521.00K
Other Non-Cash Items 9.00K 9.74M -153.00K -505
Deferred Income Tax - -152.00K 152.00K 505.00
Change in Working Capital 6.27M -2.34M 306.00K -589.00K
Operating Cash Flow -28.93M -30.82M -5.77M -6.22M
Capital Expenditures -1.18M -1.07M -2.31M -2.74M
Acquisitions - - - -
Purchase of Investments - - - -
Sales Maturities Of Investments - - - -
Other Investing Acitivies - -1.02K -2.29K -2.69K
Investing Cash Flow -1.18M -1.07M -2.31M -2.74M
Debt Repayment 5.00M 28.68M - 5.00M
Common Stock Repurchased - - - -
Dividend Paid - - - -
Other Financial Acitivies 284.00K 43.66M 7.45M 3.70M
Financial Cash Flow 5.28M 72.33K 7.45M 8.70M
Net Cash Flow -24.83M 40.44M -634.00K -253.00K
Free Cash Flow -30.11M -31.89M -8.08M -8.95M